Abstract
The aim of this study was to investigate the incidence of cardiovascular complications in hypertensive patients with erectile dysfunction (ED). An anonymous questionnaire was mailed to 467 and received from 104 hypertensive male patients. Despite the low response rate of 22%, the following interesting findings could be observed: 70.6% of the patients who responded suffered from ED. The hypertensive patients with ED had significantly higher prevalence of cardiovascular complications (P<0.05). The correlation between depression and low quality of life as well as between ED and low sexual satisfaction was also statistically significant (P=0.05). ED in hypertensive patients can be considered as a marker for cardiovascular complications in this patient group.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Johannes CB et al.. Incidence of erectile dysfunction in men 40 to 69 y old: longitudinal results from the Massachusetts male aging study. J Urol 2000 163, 460–463
Feldman HA et al.. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000 30, 328–338
Burchardt M et al.. Hypertension is associated with severe erectile dysfunction (ED). J Urol 2000 164, 1188–1191
Paffenbarger RS Jr, Hyde RT, Wing AL, Steinmetz CH . A natural history of athleticism and CV health. JAMA 1984 252, 491–495
Menotti A, Seccareccia F . Blood pressure, serum cholesterol and smoking habits predicting different manifestations of arteriosclerotic CV diseases. Acta Cardiol 1987 42, 91–102
Everson SA, Kaplan GA, Goldberg DE, Salonen JT . Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension 2000 35, 561–567
Coelho R et al.. Acute myocardial infarction: psychosocial and cardiovascular risk factors in men. J Cardiovasc Risk 1999 6, 157–162
Paulson DJ, Tahiliani AG . CV abnormalities associated with human and rodent obesity. Life Sci 1992 51, 1557–1569
Gordon DJ et al.. Predictive value of the exercise tolerance test for mortality in North American men: the Lipid Research Clinics Mortality Follow-up Study. Circulation 1986 74, 252–261
Shephard RJ . Exercise and relaxation in health promotion. Sports Med 1997 23, 211–217
Higgins M . Epidemiology and prevention of coronary heart disease in families. Am J Med 2000 108, 387–395
Rosen RC et al.. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997 49, 822–830
Fugl-Meyer AR, Lodnert G, Branholm IB, Fugl-Meyer KS . On life satisfaction in male erectile dysfunction. Int J Impot Res 1997 9, 141–148
Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley . Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health 1993 5, 179–193
Feldman HA et al.. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994 151, 54–61
Dimsdale JE . Symptoms of anxiety and depression as precursors to hypertension. JAMA 1997 277, 574–575
Jonas BS, Franks P, Ingram DD . Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Fam Med 1997 6, 43–49
Ford DE et al.. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998 158, 1422–1426
Wassertheil-Smoller S et al.. Change in depression as a precursor of CV events. SHEP Cooperative Research Group (Systolic Hypertension in the elderly). Arch Intern Med 1996 156, 553–561
Penninx BW et al.. CV events and mortality in newly and chronically depressed persons >70 y of age. Am J Cardiol 1998 81, 988–994
Thomas HE Jr, Kannel WB, Dawber TR, McNamara PM . Cholesterol–phospholipid ratio in the prediction of coronary heart disease. The Framingham study. New Engl J Med 1966 274, 701–705
Julius S, Valentini V, Palatini P . Overweight and hypertension. A 2-way street? Hypertension 2000 35, 807–813
Gus M et al.. Association of various measurements of obesity and the prevalence of hypertension. Arq Bras Cardiol 1998 70, 111–114
Tanaka K, Nakanishi T . Obesity as a risk factor for various diseases: necessity of lifestyle changes for healthy aging. Appl Human Sci 1996 15, 139–148
Njolstad I, Arnesen E . Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: a prospective analysis from the Finnmark Study. Arch Intern Med 1998 158, 1326–1332
Lamarche B et al.. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Quebec CV study. Atherosclerosis 1996 119, 235–245
Ververs MT, Verschuren WM, Boerma GJ, Kromhout D . The importance of HDL-cholesterol level determination in the classification of persons at increased risk of coronary heart disease. Ned Tijdschr Geneeskd 1992 136, 1023–1027
Seman LJ et al.. Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem 1999 45, 1039–1046
Metz P . Arteriogenic erectile impotence. Dan Med Bull 1986 33, 134–150
Virag R et al.. Impotence of vascular origin. J Mal Vasc 1989 14, 112–126
Wabrek AJ, Burchell RC . Male sexual dysfunction associated with coronary heart disease. Arch Sex Behav 1980 9, 69–75
Lue TF . Erectile dysfunction: problems and challenges. J Urol 1993 149, 1256–1257
Jeremy JY, Mikhailidis DP . Cigarette smoking and erectile dysfunction. J R Soc Health 1998 118, 151–155
Shabsigh R, Fishman IJ, Schum C, Dunn JK . Cigarette smoking and other vascular risk factors in vasculogenic impotence. Urology 1991 38, 227–231
Guirguis WR . Impotence in diabetes: facts and fictions. Diabetic Med 1992 9, 287–289
Acknowledgements
MB and TB were supported in part by the urology research fund of Columbia University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burchardt, M., Burchardt, T., Anastasiadis, A. et al. Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension. Int J Impot Res 13, 276–281 (2001). https://doi.org/10.1038/sj.ijir.3900725
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3900725
Keywords
This article is cited by
-
Hydrogen sulfide and erectile function: a novel therapeutic target
Nature Reviews Urology (2011)
-
Erektile Dysfunktion
Wiener Medizinische Wochenschrift (2009)
-
Effect of Impaza on Cardiovascular System
Bulletin of Experimental Biology and Medicine (2009)
-
A retrospective study of the relationship between biomarkers of atherosclerosis and erectile dysfunction in 988 men
International Journal of Impotence Research (2007)
-
Sexual activity after myocardial infarction: When to resume the use of erectogenic drugs
Current Sexual Health Reports (2006)